Bill
HR 5178
HR 5178 improves care for sickle cell disease by establishing specialized centers, funding research, enhancing education, and ensuring better insurance coverage for patients.
The Sickle Cell Disease Comprehensive Care Act (HR 5178) was introduced in the House of Representatives on September 8, 2025. This legislation aims to enhance the quality of care and support for individuals living with sickle cell disease (SCD), a genetic blood disorder that affects millions of people in the United States.
The primary intent of HR 5178 is to establish a comprehensive framework for the management and treatment of sickle cell disease. The bill seeks to improve access to care, promote research, and enhance educational resources for patients, families, and healthcare providers.
While the specific text of the bill is not provided, typical provisions in similar legislation may include:
Establishment of Care Centers: Creation of specialized sickle cell disease care centers to provide coordinated and comprehensive treatment.
Funding for Research: Allocation of federal funds to support research initiatives aimed at improving treatment options and understanding the disease better.
Patient Education Programs: Development of educational resources to inform patients and families about sickle cell disease management and available services.
Insurance Coverage Improvements: Mandating that insurance plans cover necessary treatments and medications for sickle cell disease without excessive out-of-pocket costs.
The bill would primarily impact:
Individuals with Sickle Cell Disease: Enhancing their access to specialized care and treatment options.
Healthcare Providers: Offering them additional resources and training to better manage sickle cell disease.
Researchers: Providing funding and support for studies aimed at improving understanding and treatment of the disease.
The bill is sponsored by Neal P. Dunn and has numerous cosponsors, including notable representatives such as:
HR 5178 has a companion bill in the Senate, S 721, which may parallel its objectives and provisions.
The Sickle Cell Disease Comprehensive Care Act represents a significant step towards improving the lives of those affected by sickle cell disease through enhanced care, research, and education. As the bill progresses through the legislative process, it will be essential to monitor its developments and potential impacts on the healthcare landscape for sickle cell disease.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
